Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
European Commission Decision to approve the pediatric use of antifungal…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 27, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the European Commission (EC) has extended the indications of the antifungal Cresemba ®(isavuconazole) to pediatric patients and also granted an extension of market exclusivity by two additional years,...
Nasdaq GlobeNewswire
27/08/2024
Probiotic Skin Care Cosmetic Product Market to Reach $981.3 Million, Globally…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A06317 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A06317 Prime determinants of growth Increase in consumer awareness about the benefits of probiotics for skin health has fueled demand, as probiotics are known to balance the skin microbiome, reduce inflammation, and enhance skin barrier function. Growing interest in natural and organic...
PR Newswire
27/08/2024
Bone Harvester Market to Reach $23.4 Million, Globally, by 2033 at 5.7% CAGR…
The global bone harvester market is experiencing growth due to surge in geriatric population, high adoption of bone marrow transplantation, and rise in prevalence of orthopedic disorders. Furthermore, the developing healthcare infrastructure in the developing nations such as India, China, and Middle Eastern countries is expected to provide significant opportunity for growth. The global bone harvester market is experiencing growth due to surge in geriatric population, high adoption of bone...
PR Newswire
27/08/2024
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric…
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 27, 2024 - Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, and Indivior PLC (NASDAQ/LSE: INDV) today announced the selection of clinical candidates from their GABAB positive allosteric modulator (PAM) research collaboration. Indivior has selected a compound for future...
Nasdaq GlobeNewswire
27/08/2024
Roche's PiaSky approved in the EU as the first monthly subcutaneous treatment…
With the option to self-administer, PiaSky® (crovalimab) has the potential to reduce treatment burden for people with paroxysmal nocturnal haemoglobinuria (PNH) in Europe and their caregiversApproval is based on COMMODORE 2, where subcutaneous (SC) PiaSky once a month was equivalent to intravenous eculizumab every two weeks 1,2 PiaSky advances C5 inhibitionthrough innovative recycling technology, which enables its monthly SC administration 3Basel, 27 August 2024 - Roche...
Nasdaq GlobeNewswire
27/08/2024
IBA secures deal with the University of Pennsylvania Health System for two…
Agreement further strengthens the long-term relationship between IBA and the University of PennsylvaniaLouvain-La-Neuve, Belgium, August 27, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a Memorandum of Understanding with the University of Pennsylvania Health System for the installation of two Proteus ® ONE 1...
Nasdaq GlobeNewswire
27/08/2024
Kanazawa University research: Atomic force microscopy upgrade captures 3D images…
The hypothesis of a hydration layer forming during the dissolution of calcite was prompted by simulations of the process, which pointed to the production of a Ca(OH)2 layer across 'transition regions' as calcite dissolves. Despite being unstable in the bulk or on flat terraces, Ca(OH)2 can appropriate some stability from step edge structures, although the mechanism behind this is not well understood. This could explain the stability of the Ca(OH)2 next to the step edges but since the transition…
PR Newswire
27/08/2024
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence…
Avance Clinical comprehensively supports biotech clients through all clinical trial stages—including protocol development, site selection, patient recruitment, and data analysis—and eliminates the need to engage with multiple CROs. This streamlined approach optimizes clinical study efficiencies, minimizes overall costs, and accelerates trial timelines. Moreover, Avance Clinical, as a midsized entity, embeds itself deeply into its biotech customers' operations, with its scientific and regulatory…
PR Newswire
27/08/2024
Telix Announces Reorganisation to Deliver on Strategic Priorities
As part of this initiative, the Company announces three leadership changes: As part of this initiative, the Company announces three leadership changes: Darren Patti remains Group Chief Operating Officer, with leadership responsibility for Telix's internal manufacturing operations, including the operations of ARTMS, IsoTherapeutics and Optimal Tracers, which sit under the TMS umbrella. DrChristian Behrenbruch, Telix Managing Director and Group Chief Executive Officer said the new...
PR Newswire
27/08/2024
Global Wireless Brain Sensors Market to Accelerate Substantially at a CAGR of…
Key Takeaways from the Wireless Brain Sensors Market Report Key Takeaways from the Wireless Brain Sensors Market Report To read more about the latest highlights related to the wireless brain sensors market, get a snapshot of the key highlights entailed in the Global Wireless Brain Sensors Market Report Wireless Brain Sensors Overview Wireless brain sensors are a cutting-edge technology in the field of neuroengineering, designed to monitor brain activity without the need for...
PR Newswire
26/08/2024
Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among…
Currently, as per the WHO, the vast majority of schizophrenia patients around the world are not receiving mental health care. Approximately 50% of people in mental hospitals have a schizophrenia diagnosis, and only 31.3% of people with psychosis receive specialist mental health care. Currently, as per the WHO, the vast majority of schizophrenia patients around the world are not receiving mental health care. Approximately50%of people in mental hospitals have a schizophrenia diagnosis, and...
PR Newswire
26/08/2024
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
ndAnnual Global Healthcare Conference on Wednesday, September 4, 2024. The presentation will begin at 11:30 A.M. Eastern Time. To access a live webcast of the presentation, visit Teva's Investor Relations website athttps://ir.tevapharm.com/Events-and-Presentations.An archived version of the webcast will be available within 24 hours after the end of the live discussion. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a...
Nasdaq GlobeNewswire
26/08/2024
Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell…
® -mediated gene editing capabilities for design of SMART DUAL CAR T-cells, which efficiently target immunotherapy recalcitrant solid tumors while mitigating potential safety risks. Adoptive cell therapy based on CAR T cells has proven to be lifesaving for many cancer patients. However, its therapeutic efficacy has so far been restricted to only a few malignancies, with solid tumors proving to be especially recalcitrant to efficient therapy.One key factor for this are cancer-associated...
Nasdaq GlobeNewswire
26/08/2024
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Media ReleaseCOPENHAGEN, Denmark; August 26, 2024 Genmab A/S (Nasdaq:GMAB) announced today thatits Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Morgan Stanley 22 ndAnnual Global Healthcare Conference at 1:05PM EDT / 7:05PM CEST on September 4 , 2024. A webcast of the event, which will include brief opening remarks followed by a...
Nasdaq GlobeNewswire
26/08/2024
Ultraviolet Visible Spectroscopy Market worth $1.7 billion by 2029 driven by…
Browse in-depth TOC on "Ultraviolet Visible Spectroscopy Market" Browse in-depth TOC on "Ultraviolet Visible Spectroscopy Market" 223 - Tables 61 - Figures252 - Pages Agilent Technologies, Inc.: Global Provider of Spectroscopy Solutions Agilent Technologies (US) is a leading player in the diagnostics, life sciences, and chemical sectors, offering a range of spectroscopy equipment. The company operates through three primary segments: Life Sciences & Applied Markets,...
PR Newswire
26/08/2024
Injection Pen Market worth $74.1 billion by 2030 driven by Emerging Tech…
Browse in-depth TOC on "Injection Pen Market" Browse in-depth TOC on "Injection Pen Market" 213 - Tables 62 - Figures 242 - Pages Novo Nordisk A/S: Leading Innovator in Injection Pens Novo Nordisk ( Denmark ) emerged as the top player in the global injection pen market in 2023. The company's Diabetes Care segment, which focuses on reusable injection pens, is both its largest and fastest-growing area. Novo Nordisk also provides injection pens for growth hormone treatments...
PR Newswire
26/08/2024
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 26 August 2024– On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024.Under the...
Nasdaq GlobeNewswire
26/08/2024
EURneffy (adrenaline nasal spray) Approved in the EU as the First and Only…
EURneffyoffers adults and children (≥30 kg) in Europe living with severe allergic reactions the first new delivery method for adrenaline in more than 30 years in the EU European Commission decision follows FDA approval in the United States on August 9, 2024 SAN DIEGO, Aug.26, 2024(GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to the development of products to better protect patients from severe allergic reactions that...
Nasdaq GlobeNewswire
26/08/2024
About Circul VS: A Core Continuous Blood Pressure Measurement Technology System…
Utilizing state-of-the-art ultrasound sensing technology and intelligent algorithms, Circul VS provides continuous, real-time blood pressure waveform data with exceptional accuracy. This innovative technology is the result of comprehensive market research and extensive clinical studies. Utilizing state-of-the-art ultrasound sensing technology and intelligent algorithms, Circul VS provides continuous, real-time blood pressure waveform data with exceptional accuracy. This innovative technology…
PR Newswire
26/08/2024
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare…
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Members of the management team will hold an in-person fireside chat on September 5, 2024, starting at 5:35 pm EDT (21:35 GMT).A live audio webcast of the fireside chat will be available and can be accessed either during or after the event in the...
Nasdaq GlobeNewswire
26/08/2024
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency…
- Utilize dual internal controls to ensure highly reliable test results - Utilize dual internal controls to ensure highly reliable test results - Pledges to supply assays meeting the needs of respective countries SEOUL, South Korea,Aug. 26, 2024/PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today that it has developed its PCR test assays in response to the public health emergency of...
PR Newswire
26/08/2024
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical…
®Brands will exhibit at the 46 thESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy on September 7-10, 2024. ESPEN 2024 offers a unique platform for companies to present and educate on innovative science in clinical nutrition and metabolism, fostering collaboration with physicians, dietitians, pharmacists, nutritionists, scientists, and nurses. The NAI and CarnoSyn ®Brands team will be available at stand #16 to discuss the latest clinical evidence of TriBsyn™, a...
Nasdaq GlobeNewswire
26/08/2024
Zero Candida Announces Launch of New Website
The company is in the process of applying to the TSX Venture Exchange in Canada to list its shares at a proposed valuation of 40 million Canadian dollars. The company is in the process of applying to the TSX Venture Exchange inCanadato list its shares at a proposed valuation of40 million Canadian dollars. Zero-Candida's technology is a game-changer that has the potential to change the treatment of women and FemTech industry in the world. The first of its kind technology using a...
PR Newswire
26/08/2024
INTRODUCING GLOBAL SUPERSTAR GIGI HADID AS A NEW AMBASSADOR FOR MILLION GOLD FOR…
This year, Rabanne makes its boldest ambassador appointment yet, proudly announcing global megastar Gigi Hadid as the face of Million Gold For Her: The first in a visionary new fragrance universe that captures the most intoxicating and exhilarating facets of femininity in an ultra-desirable bottle featuring the XL link of Rabanne's signature jewelry. This year, Rabanne makes its boldest ambassador appointment yet, proudly announcing global megastar Gigi Hadid as the face ofMillion Gold...
PR Newswire
26/08/2024
Altri Comunicati
